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Leukocyte telomere length is shorter in response to chronic disease processes associatedwith inflammation such as diabetesmellitus
and coronary artery disease. Data from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2002 was
used to explore the relationship between leukocyte telomere length and presumed NAFLD, as indicated by elevated serum alanine
aminotransferase (ALT) levels, obesity, or abdominal obesity. Logistic regression models were used to evaluate the relationship
between telomere length and presumed markers of NAFLD adjusting for possible confounders. There was no relationship between
elevated ALT levels, abdominal obesity, or obesity and telomere length in adjusted models in NHANES (OR 1.13, 95% CI 0.48–2.65;
OR 1.17, 95% CI 0.52–2.62, resp.). Mexican-American men had shorter telomere length in relation to presumed NAFLD (OR 0.07,
95% CI 0.006–0.79) and using different indicators of NAFLD (OR 0.012, 95% CI 0.0006–0.24). Mexican origin with presumed
NAFLD had shorter telomere length than men in other population groups. Longitudinal studies are necessary to evaluate the role
of telomere length as a potential predictor to assess pathogenesis of NALFD in Mexicans.
1. Background
1.1. Nonalcoholic Fatty Liver Disease. Latinos are at high risk
for specific complications from obesity including NAFLD
[1] and insulin resistance compared with other population
groups with the prevalence being higher in Latinos of Mexi-
can and Central American origin than Latinos of Caribbean
origin [2]. Furthermore, Latino males are at higher risk than
Latino females [1].
1.2. Genetics and Nonalcoholic Fatty Liver Disease. Previous
research has demonstrated that there is a clear genetic com-
ponent (variants of the gene PNPLA3, I148M) to increased
risk for NAFLD in Latinos of Mexican and Central American
background [3]. A single nucleotide polymorphism (SNP)
(rs738409) in PNPLA3 encodes an amino acid substitution,
which results in a twofold higher liver fat accumulation
among those with a GG genotype of the allele [3].Meanwhile,
however, the variant increases risk for women, not men, and
Mexican and Central American origin Latinos men are at
higher risk for NAFLD than women [3]. Furthermore, the
addition of genetic markers to predict risk for NAFLD does
not improve discriminatory ability of common clinical risk
factors, suggesting the need for other biomarkers beyond
genetic variants [4].
1.3. Telomere Length and Metabolic Disease. Cross-sectional
data suggest that shorter telomere length could be a useful
indicator of risk for metabolic disease. Studies in adults
suggest that components of metabolic dysfunction including
insulin resistance, abdominal obesity, and hypertension are
associated with shorter telomere length [5]. Shorter telomere
length also predicts development of type 2 diabetes mellitus
[6] and progression of the metabolic syndrome [7].
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In this study, we evaluate the role of leukocyte telomere
length in presumedNAFLD in a population ofUS adults from
two cycles of the National Health and Nutrition Examination
Survey (NHANES) that tested leukocyte telomere length,
with a focus on the relationship between telomere length and
liver disease stratified by ethnic and racial background and
gender.
2. Methods
2.1. Data Source and Sample. TheNational Health andNutri-
tion Examination Survey (NHANES) is a nationally repre-
sentative survey of the noninstitutionalized US population.
Weused information from the questionnaire, laboratory, diet,
and physical examination components for our analysis of
the 1999-2000 through 2001-2002 surveys, as these included
telomere measurements in a subset of the population aged
20 years and older that had blood collected for DNA
purification. These years were the only two cycles of the
NHANES that assessed telomere length. The total number of
individuals was 3,567 in 1999-2000 and 4,260 in 2001-2002.
All NHNAES participants 20 years old and over were asked
to provide DNA samples. Of those who provided samples
(10,291), 7,827 (76%) specifically allowed future DNA use
and were tested for leukocyte telomere length [8]. The same
laboratory, dietary, and physical exammeasures were used in
the two different cycles of NHANES. NHANES is approved
by theNational Center for Health Statistics (NCHS) Research
Ethics Review Board, and written informed consent was
obtained from participants. The Institutional Review Board
at the University of California, San Francisco (Committee for
Human Research (CHR)), exempted the present study from
review.
2.2. Nonalcoholic Fatty Liver Disease. Our primary study
outcomewas the presence or absence of NAFLD. Participants
were determined to have NAFLD using different indicators;
if they had elevated serum alanine aminotransferase (ALT)
levels (ALT≥ 29U/L) formen and≥22 forwomen [9].Wehad
a secondary definition of NAFLD, which combined elevated
serum ALT levels with abdominal obesity (for men > 102
centimeters and for women > 88 centimeters) [10] and a third
one, which combined elevated serum ALT levels with obesity
(defined using the Center for Disease Control’s cut point of
having a body mass index ≥ 30 kg/m2). Individuals who had
elevated serum ALT levels and abdominal obesity or overall
obesity were compared with participants who had neither.
Those who had one indicator of presumed nonalcoholic fatty
liver disease such as elevated ALT or obesity (abdominal or
high body mass index (BMI)) were excluded from analyses
that focused on definitions of NAFLD that included both
obesity and liver enzymes so as to have a cleaner comparison
group. Participants who were known to have Hepatitis B or
C, HIV, and known liver disease, were currently pregnant,
and had daily consumption of alcohol or known exposure
to hepatotoxic medication were excluded from all analyses.
Final sample size for the dataset was 7070 after excluding
those with the conditions (𝑛 = 757).
2.3. Leukocyte Telomere Length Measurements. The telomere
assays were conducted in the Blackburn Laboratory at the
University of California, San Francisco. The Centers for Dis-
ease Control conducted a quality control review assessment
before linking the leukocyte telomere length results with
NHANES public files.
Briefly, aliquots of purified DNA were provided by
the National Center for Health Statistics to the Blackburn
Laboratory. DNA was isolated from whole blood using
the Puregene (D-50K) kit protocol (Gentra Systems, Inc.,
Minneapolis, Minnesota) and stored at −80∘C. To measure
mean leukocyte telomere length, quantitative polymerase
chain reaction (PCR) assay was used to determine the relative
ratio of telomere repeat copy number to single-copy reference
DNAnumber (T/S ratio) as previously described by Cawthon
(2002) [11].The single-copy gene used as a control was human
beta-globin [8]. The interassay coefficient of variability for
LTL was 4%.
2.4. Control for Potential Confounders. Potential confounders
included in multivariate analysis included age in years (as
continuous), age squared (based on the potential for nonlin-
earity between age and telomere length [12, 13]), educational
attainment (less than high school, high school, or more
than high school), place of birth (US born or foreign born),
marital status (married or unmarried), and poverty to income
ratio (the ratio of household income to poverty adjusted to
family size and inflation). All variables were based on self-
reported status and were found to be significant predictors
for leukocyte telomere length [8]. Race/ethnicity included
White, Black, Mexican-American, other Hispanic, and others
or mixed race. We also adjusted for cell type composition
including white blood cells (SI), lymphocytes (%), monocytes
(%), neutrophils (%), eosinophils (%), basophils (%), and
platelets (%), following the methodology used by Rehkopf et
al. (2016) [13].
2.5. Statistical Analysis. Univariate and multivariate analyses
were conducted using Stata 13.0 (Stata Corp, College Station,
TX). We conducted stratified analyses based on sex (male
versus female) and race/ethnicity (White, Black, Mexican-
American, otherHispanic, andmixed race) following the des-
ignations for these years ofNHANES.Wefitted an interaction
term to test the hypothesis that there is significant interaction
between race, specifically Mexican-American background,
telomere length, and presumed NAFLD as indicated by high
ALT levels. As there are significantly different patterns of
incidence for NAFLD based on ethnicity and gender, we
conducted stratified analysis in addition to pooled analyses
adjusting for the confounders described above [14, 15]. In
some cases when numbers were below 100 for stratified
analyses, calculations were not conducted. Sampling weights
as provided for NHANES for the examination were used to
take into account the complex sampling design including
clustering and stratification and were incorporated into all
analyses using Stata code.
A relatively small number of individuals (<15%) were
missing data for the various outcomes and covariates so we
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Table 1: Telomere length, race, and interaction terms on suspected nonalcoholic fatty liver disease, NHANES 1999–2002. The table included
interaction terms to assess the relationship between race/ethnicity and telomere length in relation to suspected nonalcoholic fatty liver disease
(defined by having elevated ALT levels).
Variable Odds ratio (OR) 𝑝 value Confidence interval
Female sex 1.03 0.85 0.75–1.40
Age in years 0.98 <0.01 0.97–0.99
Telomere length 1.25 0.50 0.63–2.48
Race/ethnicity
White (non- Hispanic) 1.00
Black (non-Hispanic) 0.50 0.29 0.13–1.87
Mexican-American 3.96 <0.01 1.73–9.04
Other Hispanic 0.54 0.50 0.08–3.89
Other/mixed race 22.02 0.01 2.04–237.90
Interaction terms
MexicanXtelomere 0.32 0.01 0.13–0.77
BlackXTelomere 1.36 0.70 0.38–4.87
Other Hispanic XTelomere 2.42 0.35 0.37–15.87
Other-MixedXTelomere 0.07 0.01 0.008–0.54
decided againstmultiple imputation.Model 1 had less than 1%
of data missing, models 2 and 3 had 13%missing, andmodels
4 and 5 had 14% missing.
3. Results
Our initial exploratory analyses assessing the possible role
of race and ethnic specific differences by telomere length
in predicting presumed NALFD suggested the important
role of interaction. Approximately 20–30% of the partici-
pants had the outcome in question (high ALT) with slight
differences based on race/ethnicity and gender (28.1% of
the population with telomere length measurements had ele-
vated ALT levels). Specifically, Mexican ethnicity interacted
with telomere length indicating shorter telomere lengths
for presumed NAFLD in Mexicans (OR 0.32, 95% CI
0.13–0.77) and the other/mixed race and telomere length
interaction term also indicates shorter telomere length for
presumedNAFLD in this population group (OR 0.07, 95%CI
0.0008–0.54) (Table 1). Adjusting for potential confounders
including demographics and cell type, the interaction term
for Mexican-American ethnicity became attenuated (OR
0.46, 95% CI 0.20–1.06), although it did not become atten-
uated for other/mixed race individuals (OR 0.03, 95% CI
0.004–0.24) (results not shown).
3.1. Telomere Length and Elevated ALT. In unadjusted analy-
sis, we found that longer telomere length was associated with
increased risk of elevated serum ALT levels in both sexes
(OR 1.87, 95% CI 1.19–2.94) with increased risk for men in
particular (OR 2.95, 95% CI 1.43–6.09) and highest risk for
those who self-identified as African-American males (OR
5.52, 95% CI 1.38–22.10) and other Hispanic males (OR 17.00,
95% CI 1.67–173.24) (Table 2). Non-Hispanic White males
also had increased risk based on longer telomere length (OR
3.01, 95% CI 1.32–6.91). Those that defined themselves as
others ormixed/race had increased riskwith shorter telomere
length (OR 0.14, 95% CI 0.02–0.92) (Table 2). Mexican-
Americans did not have increased risk for elevated ALT with
shorter or longer telomere length (OR0.65, 95%CI 0.31–1.35).
In adjusted analyses for demographic factors, all rela-
tionships are attenuated and lose statistical significance
with the exception of mixed race/other individuals. When
adjusting for cell type composition, African-American men
show increased risk for elevated ALT with longer telomere
length (OR 4.98, 95% CI 1.03–24.13) and mixed race/other
individuals continue to have increased risk with shorter
telomere length (Table 2).
3.2. Telomere Length and Elevated ALT and Obesity. When
elevated serum ALT levels were combined with abdominal
obesity or obesity, we found that shorter telomere length
was associated with presumedNAFLD inMexican-American
men (OR 0.15, 95% CI 0.03–0.64 for abdominal obesity;
OR 0.012, 95% CI 0.0006–0.24 for obesity) (Table 2; models
4 and 5). Mixed race/other individuals also continued to
have shorter telomere length with presumed NAFLD. Similar
to the prevalence of elevated ALT, the prevalence of the
outcome of high ALT and high waist or obesity was similar
approximately 20–30% in the population depending on
race/ethnicity (20% for high ALT and high waist and 24% for
high ALT and obesity in the population as a whole).
4. Discussion
This is the first study to assess the relationship between
presumed NAFLD and leukocyte telomere length in a
population-based sample of mixed race and ethnicity. Telom-
ere length was not associated with presumed NAFLD
after adjustment for sociodemographic confounders in the
NHANES population as a whole. However, shorter telomere
length in Mexican-origin men was significantly associated
4 International Journal of Hepatology
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with presumed NAFLD. Importantly, there were important
ethnic- and gender-specific interactions between telomere
length and presumed NAFLD that were uncovered through
stratified analyses.
Leukocyte telomeres are particularly sensitive to oxida-
tive stress and inflammation [16]. Mexican-origin men are
known to have increased risk for NAFLD with African-
American men having reduced risk compared with whites.
It is possible that shorter leukocyte telomeres may precede
the inflammatory cascade that results in development of fatty
liver disease andMexican-origin men are most susceptible to
the inflammatory processes resulting in excess fat deposits in
hepatocytes in contrast with Caucasians [17]. Other studies
have found that short telomere length contributes to the
inflammatory process responsible for many divergent disease
conditions [18]. Leukocyte telomere shortening in Mexican-
origin men may be the initial indicator regarding develop-
ment of NAFLD after elevated ALTs and obesity. Indeed,
a recent study found that leukocyte telomere shortening
predicted onset of NAFLD in Asian patients with type 2
diabetes mellitus [19].
Mexican-originmenmay be particularly sensitive to hep-
atic insults and inflammation associated with obesity, while
other population groups, particularly African-Americans,
may be more resistant to these same physiological processes.
Indeed, studies with children have shown that insulin
resistance does not have the same impact on elevated serum
ALT levels in African-Americans comparedwith Latinos [20]
and that obesity explains the association between metabolic
syndrome and elevated serum ALT levels in Latinos but not
in other population groups [21]. Of note, longer telomere
length was associated with elevated serum ALT levels in
African-Americanmen in contrast withMexican-Americans,
although this relationship disappeared after controlling for
obesity.
4.1. Mixed Race/Others and Shorter Telomere Length. We
also found that those NHANES participants classified as
others or mixed race, most commonly of Asian, Pacific
Islander, or Native American background, also had shorter
telomere length in relation to presumed NAFLD. There is
much less information on the prevalence of NAFLD inAsian-
American and Native American populations; however, it is
possible that some of the Native Americans groups may have
similar genetic backgrounds with Mexican-American and
hence elevated risk. The “others/mixed race” category also
had a small number of individuals (𝑛 = 197), which limits
the ability to assess specific models including those including
obesity and abdominal obesity. Future studies need to sample
those of mixed race and Asian, Pacific Island, and Native
American race in higher numbers such that strata-specific
analyses are possible.
4.2. Further Directions. Although the NHANES dataset does
test fasting laboratory values for glucose and insulin, the
number of samples was small as this was done in only a subset
of the larger population. Future studies should assessmarkers
of insulin resistance including HOMA levels in addition to
ALT and obesity measures as well as make use of imaging
studies or histology for better diagnosis of NAFLD. Lastly,
studies should further investigate the differential impact of
NAFLD, inflammatory process, and progression to nonal-
coholic steatohepatitis (NASH) using both leukocyte and
hepatocyte telomere lengths to better understand progression
of disease and differential impact based on ethnicity/race and
gender.
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